Literature DB >> 16319094

Infliximab-induced lupus-like reaction in a patient with psoriatic arthritis.

P Pallotta, G Cianchini, M Ruffelli, P Puddu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16319094     DOI： 10.1093/rheumatology/kei227

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  3 in total

Review 1.  Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007.

Authors:  D E Furst; F C Breedveld; J R Kalden; J S Smolen; G R Burmester; J Sieper; P Emery; E C Keystone; M H Schiff; P Mease; P L C M van Riel; R Fleischmann; M H Weisman; M E Weinblatt
Journal:  Ann Rheum Dis       Date:  2007-11       Impact factor: 19.103

2.  Infliximab-induced lupus-like syndrome in a patient with ankylosing spondylitis.

Authors:  Hatice Bodur; Filiz Eser; Sefika Konca; Serpil Arikan
Journal:  Rheumatol Int       Date:  2008-08-21       Impact factor: 2.631

3.  Infliximab-induced autoantibodies: a multicenter study.

Authors:  João Luiz Pereira Vaz; Vander Fernandes; Felipe Nogueira; Adriano Arnóbio; Roger A Levy
Journal:  Clin Rheumatol       Date:  2015-12-17       Impact factor: 2.980
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.